pCPA Activity Overview
Status | Total Negotiations | Summary |
---|---|---|
Active Negotiations | 33 | Non-oncology: 24 Oncology: 9 |
Under Consideration for Negotiation | 22 | Non-oncology: 18 Oncology: 4 |
Completed Negotiations | 398 | With Letter of Intent: 344 Without agreement: 54 |
Negotiations That Were Not Pursued | 79 |
pCPA Activity in the last four weeks
Activity for the last four weeks. Please note that these updates may take one to two weeks to be processed.
Engagement Letters Issued in the last four weeks
Brand Name | Manufacturer | Indication | Engagement Date |
---|---|---|---|
Otezla | Celgene Inc. | Psoriasis, moderate to severe plaque | |
Taltz | Eli Lilly Canada Inc. | Ankylosing spondylitis | |
Nyvepria | Pfizer Canada Inc. | febrile neutropenia in non-myeloid malignancies | |
Otezla | Celgene Inc. | Psoriatic Arthritis |